Phoenix Biotech Acquisition Corp Unit (PBAXU)
$10.37
$0.00 (0.00%)As on 14-Feb-2024 09:30EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Phoenix Biotech Acquisition Corp Unit (PBAXU)
| -3.2 | -0.1 | -2.8 | -2.3 | -- | -- | -- |
|
BSE Sensex*
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
|---|---|---|
|
Phoenix Biotech Acquisition Corp Unit (PBAXU)
| 3.9 | 2.2 |
|
S&P Small-Cap 600
| 13.9 | -17.4 |
|
BSE Sensex
| 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Phoenix Biotech Acquisition Corp Unit (PBAXU)
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages... in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California. Read more
-
CEO & Director
Mr. Christopher B. Ehrlich M.B.A.
-
CEO & Director
Mr. Christopher B. Ehrlich M.B.A.
-
Headquarters
Oakland, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Phoenix Biotech Acquisition Corp Unit (PBAXU)
What is the current share price of Phoenix Biotech Acquisition Corp Unit (PBAXU) Today?
The share price of Phoenix Biotech Acquisition Corp Unit (PBAXU) is $10.37 (NASDAQ) as of 14-Feb-2024 09:30 EDT. Phoenix Biotech Acquisition Corp Unit (PBAXU) has given a return of -2.26% in the last 1 years.
What is the current PB & PE ratio of Phoenix Biotech Acquisition Corp Unit (PBAXU)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-354.84 |
95.98 |
2021 |
-- |
-- |
2022 |
-354.84 |
95.98 |
2021 |
-- |
-- |
What is the 52 Week High and Low of Phoenix Biotech Acquisition Corp Unit (PBAXU)?
The 52-week high and low of Phoenix Biotech Acquisition Corp Unit (PBAXU) are Rs -- and Rs -- as of 27-Aug-2026.
What is the market cap of Phoenix Biotech Acquisition Corp Unit (PBAXU)?
Phoenix Biotech Acquisition Corp Unit (PBAXU) has a market capitalisation of -- as on 28-Feb-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in Phoenix Biotech Acquisition Corp Unit (PBAXU)?
Before investing in Phoenix Biotech Acquisition Corp Unit (PBAXU), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.